Enhanced [3H]DOPA and [3H]Dopamine Turnover in Striatum and Frontal Cortex In Vivo Linked to Glutamate Receptor Antagonism

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Neurochemistry

• Publication date

  1998-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1046/j.1471-4159.1998.70051979.xPMID 9572282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine Receptors

  2018cited by this paper
• Amantadine and the glutamate hypothesis of schizophrenia Experiences in the treatment of neuroleptic malignant syndrome

  2005cited by this paper
• Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatment

  2005cited by this paper
• On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.

  1997cited by this paper
• A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction.

  1997cited by this paper
• Quantification of Neuroreceptors in the Living Human Brain: IV. Effect of Aging and Elevations of D2-Like Receptors in Schizophrenia and Bipolar Illness

  1997cited by this paper
• Sensitization of the striatal dopaminergic system induced by chronic administration of a glutamate antagonist in the rat.

  1997cited by this paper
• In Vivo Regulation of DOPA Decarboxylase by Dopamine Receptors in Rat Brain

  1997cited by this paper
• Dopamine receptors in schizophrenia.

  1996cited by this paper
• The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis.

  1996cited by this paper
• In schizophrenia, some dopamine D2-like receptors are still elevated.

  1996cited by this paper
• Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys.

  1996cited by this paper
• Regulation of DOPA Decarboxylase Activity in Brain of Living Rat

  1995cited by this paper
• L‐Dihydroxyphenylalanine and its decarboxylase: New ideas on their neuroregulatory roles

  1995cited by this paper
• Dopamine receptors in schizophrenia.

  1995cited by this paper
• Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

  1995cited by this paper
• ORIGINAL ARTICLES Age-Specific Neurotoxicity in the Rat Associated with NMDA Receptor Blockade: Potential Relevance to Schizophrenia?

  1995cited by this paper
• Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene.

  1995cited by this paper
• Dizocilpine enhances striatal tyrosine hydroxylase and aromatic L-amino acid decarboxylase activity.

  1995cited by this paper
• Glutamate receptor dysfunction and schizophrenia.

  1995cited by this paper
• Elevated dopa decarboxylase activity in living brain of patients with psychosis.

  1994cited by this paper
• A Kinetic Analysis of 6‐[18F]Fluoro‐l‐Dihydroxyphenylalanine Metabolism in the Rat

  1994cited by this paper
• Striatal L‐DOPA Decarboxylase Activity in Parkinson's Disease In Vivo: Implications for the Regulation of Dopamine Synthesis

  1993cited by this paper
• Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum.

  1992cited by this paper
• Dopaminergic mechanisms in the pathogenesis of schizophrenia 1

  1992cited by this paper
• The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms.

  1992cited by this paper
• Regulation of Aromatic l‐Amino Acid Decarboxylase by Dopamine Receptors in the Rat Brain

  1992cited by this paper
• Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

  1991influential reference
• The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats.

  1991cited by this paper
• Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice.

  1991cited by this paper
• Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.

  1990cited by this paper
• Interactions of Phencyclidine Receptor Agonist MK‐801 with Dopaminergic System: Regional Studies in the Rat

  1990cited by this paper
• The case of frontostriatal dysfunction in schizophrenia.

  1990cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• Phencyclidine-induced activation of ventral tegmental A10 dopamine neurons is differentially affected by lesions of the nucleus accumbens and medial prefrontal cortex.

  1989cited by this paper
• The Emancipation of Miss Menten

  1989cited by this paper
• MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

  1988cited by this paper
• Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.

  1986cited by this paper
• Cortical modulation of striatal function.

  1982cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977cited by this paper
• Compartmental Analysis

  1970cited by this paper
• Effect of Phencyclidine in Chronic Schizophrenics *

  1967cited by this paper
• Study of a new schizophrenomimetic drug; sernyl.

  1959cited by this paper
• The determination of enzyme inhibitor constants.

  1953cited by this paper

• Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity

  2022cites this paper
• Evaluation of intraperitoneal [ 18 F]-FDOPA administration for micro-PET imaging in 1 mice and assessment of the effect of sub-chronic ketamine dosing on dopamine 2 synthesis capacity 3

  2022cites this paper
• Animal Models for Brain Research

  2020cites this paper
• Animal Models for Brain Research

  2014cites this paper
• WITHDRAWN: Brain structural, neurochemical and neuroinflammatory markers of psychosis onset and relapse: Is there evidence for a psychosis relapse signature?

  2013cites this paper
• Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.

  2012cites this paper
• Serotonergic modulation of receptor occupancy in rats treated with l‐DOPA after unilateral 6‐OHDA lesioning

  2012cites this paper
• Reciprocal interactions between MK-801, sleep deprivation and recovery in modulating rat behaviour.

  2011cites this paper
• MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism.

  2010influential citation
• Enhancing Aromatic L‐amino Acid Decarboxylase Activity: Implications for L‐DOPA Treatment in Parkinson's Disease

  2008influential citation
• Effect of memantine on CBF and CMRO2 in patients with early Parkinson’s disease

  2008cites this paper
• Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study

  2007cites this paper
• Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.

  2001cites this paper
• Ketamine alters the availability of striatal dopamine transporter as measured by [11C]β‐CFT and [11C]β‐CIT‐FE in the monkey brain

  2001cites this paper
• SCH 23390 enhances exogenous L-DOPA decarboxylation in nigrostriatal neurons

  2000cites this paper
• Opposite effects of sulpiride and SCH 23390 on ethanol-induced striatal ascorbic acid release in intact and 6-hydroxydopamine lesioned rats.

  2000cites this paper
• Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine

  1999cites this paper
• PET Imaging of Dopamine D2 Receptors with [18F]Fluoroclebopride in Monkeys: Effects of Isoflurane- and Ketamine-Induced Anesthesia

  1999cites this paper
• Enhancement of 3H-N-methylspiperone binding but not 3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor binding in vivo

  1999cites this paper
• Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.

  1999cites this paper